Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: J Pediatr. 2021 Aug 26;239:117–125.e6. doi: 10.1016/j.jpeds.2021.08.040

Table IV.

Baseline infant characteristics by 36-week brain MRI injury score

Characteristic Overall* 36-wk MRI brain abnormality score P value
Normal (0-2) Mild (3-6) Moderate (7-10) Severe (11+)
n 220 60 (27%) 133 (60%) 23 (10%) 4 (1.8%)
Gestational age at birth, n (%) .09
 24 wk 45 (20%) 7 (16%) 31 (69%) 5 (11%) 2 (4.4%)
 25 wk 60 (27%) 16 (27%) 38 (63%) 5 (8.3%) 1 (1.7%)
 26 wk 62 (28%) 18 (29%) 37 (60%) 7 (11%) 0 (0%)
 27 wk 53 (24%) 19 (36%) 27 (51%) 6 (11%) 1 (1.9%)
 Mean (SD) wk 26.0 (1.1) 26.2 (1.0) 25.9 (1.1) 25.9 (1.1) 25.5 (1.5) .27
Birth weight, mean (SD) g 827 (180) 905 (186) 799 (166) 773 (198) 878 (148) .01
Multiple gestation .72
 Yes 53 (24%) 15 (28%) 32 (60%) 5 (9.4%) 1 (1.9%)
 No 167 (76%) 45 (27%) 101 (60%) 18 (11%) 3 (1.8%)
Sex .42
 Female 110 (50%) 36 (33%) 56 (51%) 15 (14%) 3 (2.7%)
 Male 110 (50%) 24 (22%) 77 (70%) 8 (7.3%) 1 (0.9%)
Head circumference <10th percentile .79
 Yes 42 (20%) 13 (31%) 24 (57%) 4 (9.5%) 1 (0%)
 No 173 (80%) 46 (27%) 106 (61%) 18 (10%) 3 (2.4%)
Weight <10th percentile .53
 Yes 29 (13%) 10 (34%) 16 (55%) 3 (10%) 0 (0%)
 No 191 (87%) 50 (26%) 117 (61%) 20 (10%) 4 (2.1%)
Antenatal steroids, n (%) .32
 Yes 205 (93%) 54 (26%) 126 (61%) 22 (11%) 3 (1.5%)
 No 15 (6.8%) 6 (40%) 7 (47%) 1 (6.7%) 1 (6.7%)
Apgar at 5 min <5, n (%) .10
 Yes 39 (18%) 54 (30%) 107 (59%) 18 (10%) 1 (0.6%)
 No 180 (82%) 6 (15%) 25 (64%) 5 (13%) 3 (7.7%)
Treatment assignment .31
 Epo 110 (50%) 31 (28%) 67 (61%) 12 (11%) 0 (0%)
 Placebo 110 (50%) 29 (26%) 66 (60%) 11 (10%) 4 (3.6%)
Baseline Epo level, median (IQR) 8.7 (4.5, 22.6) 11.3 (4.9,18.4) 7.4 (4.3,19.0) 8.9 (4.9, 39.2) 44.9 (30.6, 56.3) .28
*

The values for percentages in this column refer to the totals in that column while the percentages in the corresponding rows are based on the numbers of the MRI scores from normal to severe in the row.